Company intelligence / Profile preview

Precision NextGen Oncology and Research Center

Beverly Hills, California, United Statesnextgenonc.com ↗

Ownership: Private
Employees: ~49
Development stage: Commercial

Overview

Precision NextGen Oncology and Research Center is an independent oncology clinic specializing in advanced and rare cancers. It provides patient-centric care using chemotherapy, immunotherapy, targeted therapy, hormone therapy, surgery coordination—and leads early-phase oncology clinical trials with expertise in genetically targeted therapies. The center is led by Dr. Kamlesh Kumar Sankhala and has experience guiding novel drugs through first-in-human studies. No published results or pipeline data are available.

Therapeutic areas: OncologyHematology
Modalities: ChemotherapyImmunotherapyTargeted therapyHormone therapy
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Precision NextGen Oncology and Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precision NextGen Oncology and Research Center.

Explore the full profile